10 more Deaths Attributed to Use of Blood Thinner Plavix


Overview: Courthouse News Service reports that ten people died from using Plavix, according to two more Plavix lawsuits. The blockbuster blood-thinner allegedly causes heart attack, internal bleeding and other life-threatening complications. Mounting evidence suggests that, although Plavix is much more costly, it is no better than aspirin in preventing thromboembolic events.

  • Plavix is blamed for 10 more deaths, as lawsuits against the drug makers continue to be filed
  • There are at least 561 lawsuits alleging Plavix caused injuries or death
  • Research suggests that Plavix is no more effective than Aspirin at preventing blood clot, stroke or heart attack

Product: Plavix® (clopidogrel)  

Manufacturer: Sanofi-Aventis, Bristol-Myers Squibb Co.

Side Effects & Complications 

  •       Cerebral hemorrhage
  •       Thrombotic Thrombocytopenic Purpura (TTP)
  •       Gastrointestinal bleeding
  •       Ulcers
  •       Internal bleeding
  •       Bone marrow damage
  •       Heart attack
  •       Stroke
  •       Death

Plavix Lawsuits

According to Courthouse News Service, there are at least 561 lawsuits over Plavix. These suits allege that the manufacturers, Bristol-Myers Squibb and Sanofi-Aventis, knew that Plavix posed serious, potentially-fatal risks but did not warn the public. Instead, the suits claim, the drug makers invested heavily in marketing the drug. Parker Waichman, a national personal injury law firm, has filed a number of Plavix lawsuits on behalf of users who experienced injuries after taking the drug. One such case was filed in late September in the Supreme Court of the State of New York, County of New York. The lawsuit alleges that the medication caused three gastrointestinal hemorrhages in a Georgia man. Due to their persistent advertising, Plavix has become the sixth best-selling drug in the United States, despite  evidence showing that is no better than Aspirin.

Plavix No Better than Aspirin, Evidence Suggests

Plavix and Aspirin are both used to prevent blood clot, stroke and heart attack in high-risk patients. At approximately $4 a pill, Plavix is significantly more expensive than Aspirin, which costs about 4 cents a pill. Although patients pay 100 times for Plavix, research suggests that the medication is not more effective than Aspirin. One recent study, for instance, showed that Aspirin alone was nearly as effective dual therapy with Aspirin and Plavix in patients with peripheral artery disease. Furthermore, patients who take both Plavix and Aspirin have a 20 percent increased risk of bleeding, stroke, heart attack and death. Another recent study also showed that dual therapy with Aspirin and Plavix was no better than Aspirin alone at preventing strokes.